Back to Search Start Over

Supplementary Figures 1 - 5 from ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer

Authors :
Wafik S. El-Deiry
David T. Dicker
Petr B. Makhov
Marie D. Ralff
Brian C. Ross
Amriti R. Lulla
Avital Lev
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Supplementary Figure 1. UPR genes in DU145 cells. Supplementary Figure 2. ONC201 does not inhibit translocation of AR-GFP to the nucleus upon DHT treatment and does not induce AR degradation. Supplementary Figure 3. ONC201 partly synergizes with docetaxol. Supplementary Figure 4. ONC201 partly synergizes with crizotinib. Supplementary Figure 5. Biweekly measurements of mouse weights after the indicated treatments in different prostate cancer xenograft models.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....4f8b2614d3a3aa67eb7b2139d7b66ff5
Full Text :
https://doi.org/10.1158/1541-7786.22512811.v1